Impact of COVID-19 pandemic on the surgical treatment of gastric cancer
OBJECTIVE: The Coronavirus Disease 2019 (COVID-19) pandemic has been recognized as one of the most serious public health crises. This study aimed to evaluate the short-term impact of the pandemic on the surgical treatment of patients with gastric cancer (GC) in addition to their clinicopathological...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2021-11-01
|
| Series: | Clinics |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100335&tlng=en |
| _version_ | 1818245831837351936 |
|---|---|
| author | Amanda Juliani Arneiro Marcus Fernando Kodama Pertille Ramos Marina Alessandra Pereira André Roncon Dias Bruno Zilberstein Ulysses Ribeiro Junior Sergio Carlos Nahas |
| author_facet | Amanda Juliani Arneiro Marcus Fernando Kodama Pertille Ramos Marina Alessandra Pereira André Roncon Dias Bruno Zilberstein Ulysses Ribeiro Junior Sergio Carlos Nahas |
| author_sort | Amanda Juliani Arneiro |
| collection | DOAJ |
| description | OBJECTIVE: The Coronavirus Disease 2019 (COVID-19) pandemic has been recognized as one of the most serious public health crises. This study aimed to evaluate the short-term impact of the pandemic on the surgical treatment of patients with gastric cancer (GC) in addition to their clinicopathological characteristics. We also verified adherence to the COVID-19 screening protocol adopted in the institution. METHODS: All patients with GC who underwent surgical treatment between 2015 and 2021 were retrospectively evaluated and divided into two groups according to the time period: control group (2015-2019) and COVID group (2020-2021). The institutional protocol recommends that patients referred for surgery undergo RT-PCR for severe acute respiratory syndrome coronavirus 2 infection. RESULTS: A total of 83 patients were classified into the COVID group and 535 into the control group. The number of surgical procedures performed in the control group was 107 (SD±23.8) per year. Diagnostic procedures (p=0.005), preoperative chemotherapy (p<0.001), and adenocarcinomas without Lauren's subtype (p=0.009) were more frequent in the COVID group than in the control group. No significant difference was observed in the pathological characteristics and surgical outcomes of curative GC between the two groups. Evaluation of protocol compliance showed that of 83 patients with GC in the COVID group, 19 (22.9%) were not tested for COVID-19 before surgery. Two patients tested positive for COVID-19 (one preoperative and one postoperative). CONCLUSION: A decrease in the average number of surgeries and a higher frequency of diagnostic procedures occurred during the pandemic than in the previous time period. Tumor/node/metastasis classification, morbidity rates, and mortality rates in patients with GC during the pandemic did not differ from those in the previous time period. Accordingly, GC surgical treatment with acceptable screening protocol compliance could be safely performed during the COVID-19 pandemic. |
| first_indexed | 2024-12-12T14:39:10Z |
| format | Article |
| id | doaj.art-f4c780b6317a4de3be8af7e2f3743bb4 |
| institution | Directory Open Access Journal |
| issn | 1980-5322 |
| language | English |
| last_indexed | 2024-12-12T14:39:10Z |
| publishDate | 2021-11-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Clinics |
| spelling | doaj.art-f4c780b6317a4de3be8af7e2f3743bb42022-12-22T00:21:19ZengElsevier EspañaClinics1980-53222021-11-017610.6061/clinics/2021/e3508Impact of COVID-19 pandemic on the surgical treatment of gastric cancerAmanda Juliani Arneirohttps://orcid.org/0000-0001-8759-6422Marcus Fernando Kodama Pertille Ramoshttps://orcid.org/0000-0003-0200-7858Marina Alessandra Pereirahttps://orcid.org/0000-0002-6865-0988André Roncon Diashttps://orcid.org/0000-0003-3378-4916Bruno Zilbersteinhttps://orcid.org/0000-0002-1809-8558Ulysses Ribeiro Juniorhttps://orcid.org/0000-0003-1711-7347Sergio Carlos Nahashttps://orcid.org/0000-0002-2268-4146OBJECTIVE: The Coronavirus Disease 2019 (COVID-19) pandemic has been recognized as one of the most serious public health crises. This study aimed to evaluate the short-term impact of the pandemic on the surgical treatment of patients with gastric cancer (GC) in addition to their clinicopathological characteristics. We also verified adherence to the COVID-19 screening protocol adopted in the institution. METHODS: All patients with GC who underwent surgical treatment between 2015 and 2021 were retrospectively evaluated and divided into two groups according to the time period: control group (2015-2019) and COVID group (2020-2021). The institutional protocol recommends that patients referred for surgery undergo RT-PCR for severe acute respiratory syndrome coronavirus 2 infection. RESULTS: A total of 83 patients were classified into the COVID group and 535 into the control group. The number of surgical procedures performed in the control group was 107 (SD±23.8) per year. Diagnostic procedures (p=0.005), preoperative chemotherapy (p<0.001), and adenocarcinomas without Lauren's subtype (p=0.009) were more frequent in the COVID group than in the control group. No significant difference was observed in the pathological characteristics and surgical outcomes of curative GC between the two groups. Evaluation of protocol compliance showed that of 83 patients with GC in the COVID group, 19 (22.9%) were not tested for COVID-19 before surgery. Two patients tested positive for COVID-19 (one preoperative and one postoperative). CONCLUSION: A decrease in the average number of surgeries and a higher frequency of diagnostic procedures occurred during the pandemic than in the previous time period. Tumor/node/metastasis classification, morbidity rates, and mortality rates in patients with GC during the pandemic did not differ from those in the previous time period. Accordingly, GC surgical treatment with acceptable screening protocol compliance could be safely performed during the COVID-19 pandemic.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100335&tlng=enStomach NeoplasmsCoronavirusCoronavirus Disease of 2019SARS-CoV-2Surgical TreatmentPostoperative Complications |
| spellingShingle | Amanda Juliani Arneiro Marcus Fernando Kodama Pertille Ramos Marina Alessandra Pereira André Roncon Dias Bruno Zilberstein Ulysses Ribeiro Junior Sergio Carlos Nahas Impact of COVID-19 pandemic on the surgical treatment of gastric cancer Clinics Stomach Neoplasms Coronavirus Coronavirus Disease of 2019 SARS-CoV-2 Surgical Treatment Postoperative Complications |
| title | Impact of COVID-19 pandemic on the surgical treatment of gastric cancer |
| title_full | Impact of COVID-19 pandemic on the surgical treatment of gastric cancer |
| title_fullStr | Impact of COVID-19 pandemic on the surgical treatment of gastric cancer |
| title_full_unstemmed | Impact of COVID-19 pandemic on the surgical treatment of gastric cancer |
| title_short | Impact of COVID-19 pandemic on the surgical treatment of gastric cancer |
| title_sort | impact of covid 19 pandemic on the surgical treatment of gastric cancer |
| topic | Stomach Neoplasms Coronavirus Coronavirus Disease of 2019 SARS-CoV-2 Surgical Treatment Postoperative Complications |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100335&tlng=en |
| work_keys_str_mv | AT amandajulianiarneiro impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer AT marcusfernandokodamapertilleramos impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer AT marinaalessandrapereira impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer AT andreroncondias impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer AT brunozilberstein impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer AT ulyssesribeirojunior impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer AT sergiocarlosnahas impactofcovid19pandemiconthesurgicaltreatmentofgastriccancer |